sought
determin
whether
infect
human
coronavirus
hcov
associ
pneumonia
defin
epidemiolog
hcov
infect
rural
thailand
method
develop
realtim
reversetranscript
polymeras
chain
reaction
rtpcr
assay
panel
recogn
hcov
type
compar
hcov
infect
patient
hospit
pneumonia
outpati
influenzalik
ill
asymptomat
control
patient
septemb
august
result
studi
year
patient
pneumonia
hcov
infect
infect
studi
year
control
patient
avail
patient
pneumonia
outpati
control
patient
hcov
infect
compar
infect
control
patient
infect
hcov
type
type
combin
associ
pneumonia
adjust
odd
ratio
hcov
type
confid
interv
hcov
infect
detect
throughout
studi
year
infect
first
year
p
p
occur
januari
march
conclus
hcov
infect
infrequ
detect
rural
thailand
use
sensit
realtim
rtpcr
assay
found
associ
hcov
infect
ill
howev
note
yeartoyear
variat
preval
hcov
strain
like
influenc
result
human
coronavirus
hcov
positivestrand
envelop
rna
virus
classifi
within
famili
coronavirida
genu
coronaviru
first
identifi
mid
recogn
import
caus
common
cold
epidemiolog
studi
sinc
shown
virus
respons
mild
upper
respiratori
tract
infect
recent
establish
hcov
etiolog
includ
use
sensit
wellvalid
assay
detect
distinguish
current
recogn
hcov
type
comprehens
test
respiratori
pathogen
may
present
mix
infect
hcov
thu
may
respons
diseas
comparison
hcov
infect
asymptomat
control
patient
symptomat
patient
control
age
month
ill
present
studi
develop
sensit
specif
realtim
rtpcr
assay
panel
current
recogn
hcov
complement
previous
describ
sever
acut
respiratori
syndrom
sar
covspecif
realtim
rtpcr
assay
use
assay
panel
test
specimen
patient
hospit
pneumonia
outpati
influenzalik
ill
ili
asymptomat
control
patient
rural
thai
provinc
describ
epidemiolog
hcov
infect
rural
thailand
compar
infect
control
patient
versu
patient
pneumonia
viral
nucleic
acid
hcov
rna
use
develop
valid
realtim
rtpcr
panel
obtain
sever
sourc
see
acknowledg
hcov
prototyp
strain
atcc
atcc
avail
center
diseas
control
prevent
cdc
archiv
wherea
prototyp
strain
donat
thirtyon
avail
hcovposit
clinic
specimen
previous
identifi
rtpcr
probe
hybrid
rtpcr
sequenc
respiratori
virus
avail
specif
test
cdc
archiv
includ
laboratori
strain
influenza
viru
b
respiratori
syncyti
viru
rsv
human
parainfluenza
virus
hpiv
human
metapneumoviru
hmpv
adenoviru
rhinoviru
human
bocaviru
hbov
sarscov
rna
transcript
primer
pair
contain
rna
polymeras
promot
sequenc
use
amplifi
region
bracket
realtim
rtpcr
signatur
hcov
type
fragment
nucleoprotein
n
gene
gener
use
forward
primer
revers
primer
bp
n
gene
gener
use
forward
primer
revers
primer
bp
n
gene
gener
use
forward
primer
revers
primer
bp
replicas
gene
gener
use
previous
publish
primer
forward
revers
amplif
product
gel
purifi
use
qiaquick
gel
extract
kit
qiagen
rna
transcript
prepar
use
megashortscript
high
yield
transcript
kit
ambion
rna
transcript
purifi
use
megaclear
kit
ambion
quantifi
uv
light
spectroscopi
limitofdetect
test
serial
dilut
quantifi
rna
transcript
prepar
diluent
contain
yeast
trna
ngml
ambion
primer
probe
multipl
primer
probe
sequenc
design
identifi
typespecif
conserv
region
viral
replicas
n
gene
identifi
align
sequenc
avail
genbank
use
primer
express
version
appli
biosystem
beacon
design
version
premier
biosoft
intern
softwar
tabl
primer
probe
sequenc
describ
elsewher
probe
label
end
fam
quench
end
intern
black
hole
biosearch
technolog
sequenc
differ
repres
hcov
align
check
potenti
crossreact
realtim
assay
realtim
rtpcr
assay
realtim
rtpcr
panel
consist
differenti
hcov
monoplex
assay
run
ident
amplif
condit
reaction
mixtur
prepar
use
iscript
onestep
rtpcr
kit
probe
biorad
twentyfivemicrolit
reaction
contain
reaction
buffer
iscript
revers
transcriptas
primer
probe
nucleasefre
water
nucleic
acid
amplif
perform
icycl
iq
real
time
detect
system
biorad
follow
cycl
condit
min
cycl
min
cycl
follow
min
cycl
specimen
also
test
human
ribonucleas
p
gene
measur
nucleic
acid
integr
studi
subject
specimen
specimen
collect
patient
age
enrol
enhanc
activ
surveil
program
pneumonia
requir
hospit
sa
kaeo
provinc
thailand
period
septemb
august
previous
test
specimen
hbov
infect
gener
patient
enrol
studi
least
sign
acut
infect
eg
fever
chill
andor
abnorm
white
blood
cell
count
symptom
lower
respiratori
tract
diseas
eg
abnorm
breath
sound
tachypnea
andor
cough
physician
order
chest
radiograph
cxr
within
h
admiss
final
cxr
find
avail
present
analysi
nasopharyng
swab
acut
convalesc
serum
urin
clinic
demograph
inform
collect
patient
pneumonia
sampl
outpati
ili
defin
fever
within
previou
day
cough
sore
throat
absenc
diagnos
recruit
outpati
depart
hospit
sa
kaeo
provinc
outpati
specimen
second
year
studi
septemb
august
test
hcov
infect
nasopharyng
swab
demograph
inform
collect
outpati
particip
addit
second
studi
year
enrol
sampl
control
patient
outpati
clinic
patient
healthrel
complaint
without
fever
histori
fever
cough
sore
throat
diarrhea
within
previou
day
sought
enrol
equal
number
control
patient
patient
hospit
pneumonia
age
group
year
year
year
year
year
month
year
nasopharyng
swab
demograph
inform
collect
control
patient
nasopharyng
swab
collect
viral
transport
medium
aliquot
process
transport
describ
elsewher
swab
test
rsv
hpiv
influenza
viru
b
adenoviru
cultur
thailand
nation
institut
health
total
nucleic
acid
extract
test
influenza
viru
b
rsv
hmpv
adenoviru
rhinoviru
hbov
year
pcr
cdc
aliquot
extract
kept
hcov
test
test
sarscov
infect
acut
convalesc
serum
sampl
test
rsv
adenoviru
hmpv
inhous
eia
influenza
virus
hemagglutinationinhibit
assay
year
specimen
consid
posit
either
cultur
pcr
result
posit
greater
increas
antibodi
titer
acut
convalesc
serum
sampl
particip
inform
studi
object
written
consent
obtain
studi
protocol
review
approv
intern
review
board
cdc
thailand
ministri
public
health
statist
method
admiss
pneumonia
count
individu
includ
readmiss
day
previou
discharg
readmiss
occur
within
day
consid
admiss
compar
hcov
infect
patient
hospit
pneumonia
control
patient
studi
year
use
x
test
multivari
uncondit
logist
regress
model
control
age
group
month
ill
clinic
characterist
patient
hcov
infect
without
coinfect
compar
patient
infect
common
virus
variabl
compar
x
test
dichotom
variabl
twotail
consid
indic
statist
p
signific
analys
perform
use
sa
softwar
version
sa
institut
differ
primer
probe
combin
evalu
assay
effici
amplif
select
studi
realtim
assay
intern
specif
hcov
amplif
obtain
respiratori
viral
pathogensinclud
influenza
virus
b
rsv
hmpv
adenoviru
rhinoviru
hbov
sarscovor
human
dna
assay
success
valid
clinic
specimen
previous
shown
posit
hcov
altern
method
specimen
origin
report
posit
rtpcr
identifi
realtim
assay
confirm
sequenc
outpati
ili
hcov
infect
tabl
common
type
detect
among
outpati
hcov
detect
similar
proport
hcov
infect
among
asymptomat
control
patient
control
patient
hcov
type
detect
among
control
patient
hcov
infect
detect
age
group
except
children
year
age
compar
hcov
infect
patient
hospit
pneumonia
control
patient
studi
year
neither
hcov
infect
combin
infect
individu
hcov
type
associ
pneumonia
requir
hospit
even
control
age
month
ill
hcov
infect
adjust
odd
ratio
fewer
infect
detect
p
p
among
patient
pneumonia
among
control
patient
associ
pneumonia
appear
protect
howev
number
small
result
interpret
caution
cohort
age
group
test
hcov
patient
hcov
infect
coinfect
respiratori
virus
includ
almost
half
infect
tabl
among
patient
pneumonia
infect
hcov
viral
coinfect
among
outpati
control
patient
hcov
infect
respect
coinfect
anoth
viru
hcov
infect
detect
sa
kaeo
provinc
throughout
studi
figur
frequent
detect
hcov
type
repres
hcov
infect
studi
year
present
hcovinfect
patient
infect
cluster
januarymarch
made
infect
year
follow
year
infect
detect
month
infect
detect
indic
shift
circul
predomin
hcov
type
infect
appear
peak
septemb
detect
low
level
throughout
studi
compar
clinic
characterist
patient
pneumonia
patient
pneumonia
infect
influenza
viru
rsv
common
infect
limit
analysi
studi
year
preval
infect
highest
fifti
percent
patient
infect
fever
cough
tachypnea
receiv
oxygen
therapi
requir
mechan
ventil
statist
signific
differ
note
patient
infect
infect
influenza
viru
rsv
data
shown
differ
patient
infect
rhiniti
versu
patient
influenza
viru
infect
person
p
p
infect
wheez
admiss
versu
person
rsv
infect
patient
p
p
hcov
infect
also
similar
proport
fever
cough
tachypnea
present
studi
develop
sensit
specif
realtim
rtpcr
assay
panel
hcov
type
use
assay
panel
assess
diseas
burden
epidemiolog
hcov
infect
rural
provinc
thailand
period
infect
infrequ
detect
among
hospit
patient
pneumonia
among
outpati
ili
studi
year
asymptomat
control
patient
ill
patient
similar
proport
hcov
infect
infect
detect
significantli
higher
number
first
studi
year
howev
control
group
comparison
year
thu
rural
thailand
septemb
august
infect
hcov
occur
infrequ
unabl
show
epidemiolog
associ
hcov
type
pneumonia
requir
hospit
realtim
rtpcr
assay
hcov
type
combin
singl
test
panel
use
ident
amplif
condit
assay
panel
shown
sensit
specif
defin
target
valid
use
human
clinic
specimen
independ
confirm
posit
differ
viru
type
sampl
previous
determin
posit
use
convent
method
found
posit
neg
use
panel
exemplifi
panel
specif
relat
hcov
diagnost
tool
although
realtim
assay
describ
hcov
type
studi
fail
report
analyt
clinic
data
assay
perform
could
evalu
although
assay
panel
could
detect
discrimin
among
known
hcov
type
could
fail
detect
improperli
classifi
unrecogn
hcov
studi
repres
first
comprehens
analysi
hcov
infect
tropic
rural
popul
southeast
asia
despit
sensit
assay
found
preval
infect
hcov
low
studi
period
similar
find
recent
studi
bangkok
thailand
conduct
found
infect
young
children
acut
respiratori
tract
ill
howev
major
infect
rather
infect
proport
hcov
type
detect
similar
intern
studi
report
hcov
upper
lower
acut
respiratori
tract
ill
use
pcr
assay
present
studi
detect
infect
moreov
larger
proport
patient
detect
infect
coinfect
virus
compar
patient
infect
hcov
type
addit
year
surveil
necessari
clearli
establish
preval
circul
pattern
hcov
thailand
find
epidemiolog
associ
hcov
infect
pneumonia
howev
correl
hcov
sever
pneumonia
first
studi
year
could
assess
absenc
control
group
low
number
hcov
infect
second
studi
year
made
difficult
accur
assess
diseas
correl
given
yeartoyear
variat
preval
hcov
infect
multiyear
studi
may
abl
definit
assess
whether
associ
hcov
infect
sever
ill
exist
studi
test
asymptomat
control
subject
hcov
infect
studi
test
use
serolog
assay
mcintosh
et
al
detect
infect
children
hospit
acut
lower
respiratori
tract
diseas
control
children
noksokoivisto
et
al
fail
find
pcr
among
hospit
children
age
month
year
without
histori
respiratori
tract
ill
contrast
van
elden
et
al
found
significantli
pcr
patient
respiratori
tract
ill
bonemarrow
transplant
recipi
healthi
volunt
without
respiratori
tract
ill
howev
control
age
month
illnessadmiss
unclear
frequent
detect
among
patient
pneumonia
versu
common
cold
thu
although
numer
studi
tent
link
infect
sever
respiratori
tract
ill
mani
year
studi
control
age
month
ill
demonstr
epidemiolog
associ
infect
hcov
ill
common
cold
also
studi
demonstr
epidemiolog
associ
infect
sever
respiratori
tract
ill
relat
asymptomat
control
subject
two
studi
find
bronchoalveolar
lavag
specimen
patient
sever
ill
temper
region
hcov
infect
occur
frequent
late
winter
earli
spring
howev
report
describ
season
circul
pattern
virus
tropic
hcov
infect
detect
yearround
present
studi
howev
studi
year
infect
appear
cluster
januari
march
contrast
influenza
viru
infect
cluster
june
octob
sa
kaeo
provinc
statist
signific
differ
number
infect
year
year
suggest
yeartoyear
variat
strain
circul
previou
multiyear
studi
temper
region
made
similar
observ
studi
limit
first
number
hcov
infect
detect
among
patient
pneumonia
like
underestim
patient
admit
sa
kaeo
provinc
hospit
sign
symptom
clinic
pneumonia
cxr
taken
enrol
studi
children
sever
ill
patient
less
like
enrol
second
adult
underrepres
outpati
sampl
third
found
high
proport
patient
infect
hcov
coinfect
virus
especi
among
infect
make
difficult
determin
respons
etiolog
howev
test
virus
studi
final
exclud
possibl
control
patient
may
shed
hcov
follow
earlier
symptomat
infect
use
sensit
pcr
assay
van
elden
et
al
report
detect
hcov
day
ill
futur
studi
includ
control
subject
account
possibl
wellplan
studi
need
evalu
whether
newli
describ
virus
epidemiolog
associ
sever
respiratori
tract
ill
sought
determin
whether
infect
new
previous
recogn
hcov
type
associ
pneumonia
requir
hospit
thailand
found
low
number
hcov
infect
fail
find
associ
sever
respiratori
tract
diseas
howev
yeartoyear
variat
overal
preval
type
circul
hcov
occur
multiyear
studi
appropri
control
subject
necessari
adequ
assess
whether
associ
hcov
infect
sever
respiratori
diseas
